ClinicalTrials.gg
RecruitingNCT07468734Updated Mar 19, 2026

Shock Wave Versus Traditional Physical Therapy for Adult Chronic Knee Osteoarthritis

An interventional study of Extracorporeal shock wave therapy and Exercise therapy program in Shock Wave, Traditional Physical Therapy and Chronic Knee Osteoarthritis, sponsored by German International University. Recruiting at 1 site in Egypt. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-03-19.

Sponsored by German International University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 91 studies in Osteoarthritis, Knee with a site in Egypt — 28 open to participants now, 34 under way, 1 of them phase 3. Osteoarthritis, Knee · Egypt.

Planned enrollment
66th of 83
40 · median 62
Started
2026
with 14 others
No phase
76 of 91
22 open now
Primary completion
2026-11
later than 20 of 33 live
Registered
78th of 91
by date

Among the 91 studies in Osteoarthritis, Knee with a site in Egypt, this one is the 66th largest by planned enrollment of the 83 interventional ones that give a count, is one of 15 that started in 2026, is one of 76 with no phase, reaches primary completion later than 20 of the 33 other live ones, and was the 78th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

28 of the 91 studies in Osteoarthritis, Knee with a site in Egypt are open now. Recruiting first, the newest first:

22 more — sign in →

All 28 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 40 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 91 studies in Osteoarthritis, Knee with a site in Egypt, or all of them as a file.
02

Study summary

This study aims to compare the effectiveness of extracorporeal shock wave therapy (ESWT) versus structured therapeutic exercise in patients with chronic knee osteoarthritis (KOA), with respect to pain reduction and improvement of knee function.

Read the detailed description

Knee osteoarthritis (KOA) is a highly prevalent chronic degenerative joint disease characterized by progressive cartilage loss, chronic pain, stiffness, functional disability, and reduced quality of life in adults, particularly the elderly.

Extracorporeal shock wave therapy (ESWT) has emerged as a non-invasive physical modality that delivers acoustic pressure waves to musculoskeletal tissues, stimulating biological responses such as enhanced microcirculation, anti-inflammatory cytokine modulation, neovascularization, cartilage and bone repair processes, and decreased pain transmission.

03

Conditions studied

  • Shock Wave
  • Traditional Physical Therapy
  • Chronic Knee Osteoarthritis
04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults ≥ 40 years with clinical and radiographic diagnosis of chronic knee osteoarthritis (KOA) (Kellgren-Lawrence grade II-III).
  • Both sexes.
  • Persistent knee pain ≥ 3 months.
  • Ability to provide consent and participate in interventions.

Exclusion criteria

Exclusion Criteria:

  • Prior knee surgery within last 6 months.
  • Intra-articular injections in the last 3 months.
  • Systemic inflammatory arthritis or other neurological conditions affecting gait.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    ESWT Group

    Patients will receive extracorporeal shock wave therapy.

    Other: Extracorporeal shock wave therapy

  • Active comparator
    Exercise Therapy Group

    Patients will undergo a structured exercise therapy program.

    Other: Exercise therapy program

Interventions

  • OtherExtracorporeal shock wave therapy

    Patients will receive extracorporeal shock wave therapy.

  • OtherExercise therapy program

    Patients will undergo a structured exercise therapy program.

06

What researchers measure

Primary outcomes

  1. Change in pain intensity

    Change in pain intensity will be assessed using the Visual Analogue Scale (VAS) which is a 10-cm horizontal line used to measure pain intensity, ranging from (0) "no pain" to (10) "worst imaginable pain".

    Time frame: 5-week after intervention

Secondary outcomes

  1. Stiffness assessment

    Stiffness will be assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). WOMAC will be recorded at baseline, at the end of the intervention period, and during follow-up. Higher scores indicate greater symptom severity.

    Time frame: 5-week after intervention

  2. Assessment of physical function

    Physical function will be assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). WOMAC will be recorded at baseline, at the end of the intervention period, and during follow-up. Higher scores indicate greater symptom severity.

    Time frame: 5-week after intervention

  3. Knee range of motion

    Knee range of motion (ROM) will be assessed.

    Time frame: 5-week after intervention

  4. Incidence of adverse events

    Incidence of adverse events will be recorded.

    Time frame: 5-week after intervention

07

Study locations

1 of 1 sites recruiting
  • German International University
    Cairo, 12613, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Supporting information: Study protocol

Time frame: After the end of study for one year.

Access criteria: The data will be available upon a reasonable request from the corresponding author.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Nov 2026, 8 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 8 months is below that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 9, 2026
First posted
Mar 13, 2026
StartActual
Mar 18, 2026
Primary completionEst.
Nov 30, 2026
CompletionEst.
Nov 30, 2026
Last update
Mar 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07468734
Lead sponsor
German International University
Responsible party
Magdy Mohamed Aly Shabana (Associate Professor in Orthopedic, Physical Therapy, German International University) — Principal investigator
First posted
Mar 13, 2026
Start date
Mar 18, 2026
Primary completion
Nov 30, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Mar 19, 2026

Study contacts

Magdy M Shabana, MD
Contact
magdy.shabana@giu-uni.de
00201006053332

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion